Author:
Doz Marianne,Chouaid Christos,Com-Ruelle Laure,Calvo Eduardo,Brosa Max,Robert Julien,Decuypère Laurent,Pribil Celine,Huerta Alicia,Detournay Bruno
Abstract
Abstract
Background
Current asthma management guidelines are based on the level of asthma control. The impact of asthma control on health care resources and quality of life (QoL) is insufficiently studied. EUCOAST study was designed to describe costs and QoL in adult patients according to level of asthma control in France and Spain.
Methods
An observational cost of illness study was conducted simultaneously in both countries among patients age greater or equal to 18 with a diagnosis of asthma for at least 12 months. Patients were recruited prospectively by GPs in 2010 in four waves to avoid a seasonal bias. Health care resources utilization of the three months before the inclusion was collected through physician questionnaires. Asthma control was evaluated using 2009 GINA criteria over a 3-month period. QoL was assessed using EQ-5D-3L®.
Results
2,671 patients (France: 1,154; Spain: 1,517) were enrolled. Asthma was controlled in 40.6% [95% CI: 37.7% - 43.4%] and 29.9% [95% CI: 27.6% - 32.3%] of French and Spanish patients respectively.
For all types of costs, the percentage of patients using health care resources varied significantly according to the level of asthma control. The average cost (euros/3-months/patient) of controlled asthma was €85.4 (SD: 153.5) in France compared with €314.0 (SD: 2,160.4) for partially controlled asthma and €537.9 (SD: 2,355.7) for uncontrolled asthma (p<0.0001). In Spain, the corresponding figures were €152.6 (SD: 162.1), €241.2 (SD: 266.8), and €556.8 (SD: 762.4). EQ-5D-3L® score was higher (p<0.0001) in patients with controlled asthma compared to partially controlled and uncontrolled asthma in both countries (respectively 0.88; 0.78; 0.63 in France and 0.89; 0.82; 0.69 in Spain).
Conclusions
In both countries, patients presenting with uncontrolled asthma had a significantly higher asthma costs and lower scores of Qol compared to the others.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference30 articles.
1. Global Strategy for Asthma Management and Prevention. 2009, Global Initiative for Asthma (GINA), [Report accessed on www.ginasthma.org, in September 2011]
2. Masoli M, Fabian D, Holt S, Beasley R, Medical Research Institute of New Zealand, Wellington, New Zealand University of Southampton Southampton, United Kingdom: The Global Burden of Asthma Report, Global Initiative for Asthma (GINA). http://www.ginasthma.org/local/uploads/files/GINABurdenReport_1.pdf,
3. Afrite A, Allonier C, Com-Ruelle L, Le Guen N: L’asthme en France en 2006: prévalence et contrôle des symptômes. Issues Health Econ (Questions d'économie de la santé). 2008, 138: 1-8.
4. Urrutia I, Aguirre U, Sunyer J, Plana E, Muniozguren N, Martinez-Moratalla J, Payo F, Maldonado JA, Anto JM, Estudio de Salud Respiratoria de la Comunidad Europea: Changes in the prevalence of asthma in the Spanish cohort of the European Community Respiratory Health Survey (ECRHS-II). Arch Bronconeumol. 2007, 43 (8): 425-430.
5. Kroegel C, Wirtz H: History of guidelines for the diagnosis and management of asthma: from opinion to control. Drugs. 2009, 69 (9): 1189-1204. 10.2165/00003495-200969090-00004.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献